<DOC>
	<DOCNO>NCT01653522</DOCNO>
	<brief_summary>The purpose study determine effect triptans doxycycline neuroinflammatory marker acute migraine .</brief_summary>
	<brief_title>The Impact Triptan Doxycycline Neuroinflammatory Biomarkers Acute Migraine</brief_title>
	<detailed_description>Increased inflammatory cytokine matrix metalloproteinases ( MMPs ) recently implicate migraine . Inflammation may key player pathophysiology migraine alter blood-brain barrier ( BBB ) function . As inflammation induce MMP , MMP-9 involve BBB disruption neuropathic pain , largely derive neutrophil degranulation neutrophil-BBB interaction . The tetracycline group antibiotic may suppress MMP production neutrophil degranulation . This study aim investigate know neuroinflammatory biomarkers focus BBB breakdown acute migraine attack assess marker response conventional treatment ( triptans ) novel MMP target therapy ( doxycycline ) . This pilot project data supplement future project investigate novel therapeutic strategy MMP inhibitor migraine acute treatment prevention .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Headache Disorders , Primary</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Clinical diagnosis migraine without aura fulfill 2nd Edition The International Headache Classification ( ICHDII ) criterion Active prescription oral triptan medication abort acute migraine Tetracycline group antiinflammatory medication use precede three month Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>